PUBLISHER: Grand View Research | PRODUCT CODE: 1571721
PUBLISHER: Grand View Research | PRODUCT CODE: 1571721
The global women's digital health market size is expected to reach USD 9.53 billion in 2030 and is projected to grow at a CAGR of 20.5% from 2024 to 2030. The encouraging regulatory environment for digital solutions catering to women's fitness issues is expected to drive the growth of the market. In addition, the rise in funding for women's health start-ups is one of the key growth factors as the investors are now attracted to this market.
The regulatory agencies have approved digital health applications specifically focusing on women's care. For instance, the FDA approved Ava, a fertility tracking wearable device and mobile application developed by Natural Cycles, as a class-one medical device in 2016. Ava received CE approval as a class-two medical device in 2017.
Women's healthcare is gradually moving beyond reproductive health. Breast cancer, cardiovascular diseases, cervical cancer, maternal mortality, and mental diseases significantly contribute to the burden of women's health issues. The government and various private organizations are now focusing on women's fitness particularly and developing prominent solutions to address the issues.
The Covid-19 pandemic has reshaped the healthcare scenario as many countries implemented tough lockdown and millions of women living in developing/underdeveloped countries were unable to access required maternal care and contraceptives. In some countries, reproductive health issues were classified as non-essential services during the pandemic. Therefore, the implementation of digital fitness solutions such as mobile apps and wearable tracking devices witnessed significant growth in 2020.